Company Profile

Calmark Sweden AB is a Sweden-based Company providing patient-near-term testing (PNA) specialized in newborns. Its main focus is to develop medical diagnostic biotechnology. The Company focuses on the development of solutions for point-of-care detection of critical illness. Calmark Sweden AB supports physicians and other healthcare professionals to detect illness independently of the cause and regardless of the symptoms.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

11/05/24	Certain Shares of Calmark Sweden AB are subject to a Lock-Up Agreement Ending on 11-MAY-2024.	CI
07/03/24	Calmark delisted from Spotlight due to bankruptcy	FW
06/03/24	Calmark's bankruptcy petition granted	FW
05/03/24	Calmark trading halted on Spotlight after bankruptcy announcement	FW
05/03/24	Calmark files for bankruptcy	FW
20/02/24	Calmark Sweden AB Reports Earnings Results for the Full Year Ended December 31, 2023	CI
20/02/24	Calmark Sweden AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI
20/02/24	Calmark reduced its loss - has several ongoing discussions with partners	FW
07/02/24	Calmark extends the shelf life of its test cassettes	FW
05/02/24	Calmark Sweden Relaunches Point-of-Care Instrument in Finland	MT
05/02/24	Calmark Sweden AB Relaunches Neo-Bilirubin in Finland	CI
05/02/24	Calmark relaunches Neo-Bilirubin in Finland	FW
01/02/24	Calmark Sweden Wins Repeat Order for Point-of-Care Instrument in Greece	MT

30/12/23	Envirologic this year's winner and Eurocine this year's loser on Spotlight 2023	FW
30/12/22	ES Energy Save became this year's price rocket and Rhovac this year's worst share on Spotlight	FW

19/01/23	Calmark: Calmark's Neo instrument is registered in India	PU
26/09/22	Calmark: The distributor agreement for Sweden with Triolab is not extended	PU
27/10/21	Calmark brings forward publication of interim report for Q3	AQ
22/10/21	Calmark Sweden : The Board of Directors of Calmark Sweden AB (publ) resolves to carry out a rights issue of approx. MSEK 24.9 and a directed issue of approx. MSEK 2.1, and brings forward the interim report for Q3 2021	AQ
18/10/21	Calmark Sweden : intensifies efforts in India	AQ

Manager	Title	Age	Since
Camilla Arneving CEO	Chief Executive Officer	-	01/11/2022
Peter Larsson DFI	Director of Finance/CFO	-	-
Michael Lundh LAW	General Counsel	-	01/10/2020

Director	Title	Age	Since
Anders Mathias Karlsson CHM	Chairman	54	01/01/2016
Kjersti Berg Marthinsen CHM	Chairman	54	01/01/2020
Anna-Karin Edstedt Bonamy BRD	Director/Board Member	52	01/01/2018

Calmark Sweden AB Stock

Stocks

CALMA B

SE0011116524

Advanced Medical Equipment & Technology

Latest news: Calmark Sweden AB

Analysts' recommendations: Calmark Sweden AB

Press Releases: Calmark Sweden AB

Quotes and Performance

Managers and Directors: Calmark Sweden AB

Other Advanced Medical Equipment & Technology

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CALMARK SWEDEN AB	-2.89%	-2.20%	-	-	1.08M
THERMO FISHER SCIENTIFIC, INC.	-2.06%	-0.33%	+20.31%	+52.52%	253B
DANAHER CORPORATION	-1.83%	-2.15%	+5.85%	+18.13%	160B
INTUITIVE SURGICAL, INC.	+1.12%	-3.27%	-18.23%	+57.21%	151B
BOSTON SCIENTIFIC CORPORATION	+5.57%	-2.76%	-56.00%	-15.61%	64.23B
SIEMENS HEALTHINEERS AG	+1.19%	+2.62%	-10.64%	-8.42%	54.11B
EDWARDS LIFESCIENCES CORPORATION	+1.36%	+2.98%	+13.11%	+42.32%	53.76B
VEEVA SYSTEMS INC.	-1.90%	-3.51%	+5.43%	+61.66%	49.71B
AGILENT TECHNOLOGIES, INC.	-1.65%	-2.26%	+17.51%	+64.63%	48.49B
WATERS CORPORATION	-2.85%	-1.41%	+28.58%	+83.18%	44.17B
Average	-0.58%	-0.76%	+0.66%	+39.51%	97.69B
Weighted average by Cap.	-0.63%	-0.75%	+2.53%	+40.43%